Levexa

Levexa

levetiracetam

Manufacturer:

Amarox
Concise Prescribing Info
Contents
Levetiracetam
Indications/Uses
Adjunctive treatment of partial onset of seizures w/ or w/o secondary generalisation in patients w/ epilepsy.
Dosage/Direction for Use
Daily dose is administered in 2 equally divided doses. Adult & adolescent ≥16 yr Initially 500 mg twice daily, may be increased up to 1,500 mg twice daily. Dose changes can be made in 500 mg twice daily increments or decrements every 2-4 wk. Patient w/ renal impairment CrCl >80 mL/min 500-1,500 mg twice daily, 50-79 mL/min 500-1,000 mg twice daily, 30-49 mL/min 250-750 mg twice daily, <30 mL/min 250-500 mg twice daily. End-stage renal disease patient undergoing dialysis 750 mg loading dose on 1st day, then 500-1,000 mg once daily. Followed by 250-500 mg supplemental dose after dialysis.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to levetiracetam or other pyrrolidone derivatives.
Special Precautions
Discontinue treatment gradually. Assess renal function prior to dose selection in patients w/ severely impaired hepatic function. May affect ability to drive or operate machinery. Not to be used during pregnancy. Not recommended during breast-feeding.
Adverse Reactions
Somnolence, asthenia & dizziness.
MIMS Class
ATC Classification
N03AX14 - levetiracetam ; Belongs to the class of other antiepileptics.
Presentation/Packing
Form
Levexa FC tab 250 mg
Packing/Price
3 × 10's
Form
Levexa FC tab 500 mg
Packing/Price
2 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in